Clinical Trials Browser

Phase 2 × Nonseminomatous germ cell tumor × Genitourinary × Clear all

Nonseminomatous germ cell tumor, Genital Neoplasms, Female, Genital Neoplasms, Male, Mediastinal Neoplasms, Neoplasms, Germ Cell and Embryonal, Ovarian Neoplasms, Testicular Neoplasms

NCT02689219 2019-12-10

Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors

Phase 2 Terminated

18 enrolled 13 charts

Genitourinary

Nonseminomatous germ cell tumor, Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms, Carcinoma, Embryonal

Clinical Trials

Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors

Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors